MMS:NYE-Maximus Inc. (USD)

EQUITY | Specialty Business Services | New York Stock Exchange

Last Closing

USD 80.43

Change

-0.20 (-0.25)%

Market Cap

USD 3.69B

Volume

0.21M

Analyst Target

USD 81.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Maximus Inc provides business process services to government health and human services agencies in the United States and to foreign governments.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Specialty Business Services

Symbol Name Price(Change) Market Cap
RELX Relx PLC ADR

+0.05 (+0.12%)

USD 77.59B
TRI Thomson Reuters Corp

+0.02 (+0.01%)

USD 68.78B
GPN Global Payments Inc

+0.21 (+0.19%)

USD 32.12B
RTO Rentokil Initial PLC

-0.14 (-0.53%)

USD 15.24B
RBA RB Global Inc.

+0.12 (+0.17%)

USD 13.73B
ARMK Aramark Holdings

+1.11 (+3.61%)

USD 8.07B
DLB Dolby Laboratories

-0.31 (-0.37%)

USD 7.89B
DNP DNP Select Income Closed Fund

+0.05 (+0.57%)

USD 6.24B
CBZ CBIZ Inc

-0.07 (-0.09%)

USD 3.80B
UNF Unifirst Corporation

+1.23 (+0.75%)

USD 3.06B

ETFs Containing MMS

RFV Invesco S&P MidCap 400® .. 2.70 % 0.35 %

+0.24 (+-0.49%)

USD 0.30B
SDIV:SW Global X SuperDividend UC.. 1.51 % 0.00 %

-0.04 (-0.49%)

USD 0.08B
PSM 0.59 % 0.00 %

N/A

N/A
WBIA 0.00 % 1.08 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Specialty Business Services) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.09% 32% F 26% F
Dividend Return 0.36% 31% F 20% F
Total Return -3.73% 32% F 24% F
Trailing 12 Months  
Capital Gain -3.85% 32% F 29% F
Dividend Return 1.39% 35% F 18% F
Total Return -2.46% 32% F 23% F
Trailing 5 Years  
Capital Gain 9.73% 52% F 53% F
Dividend Return 7.61% 53% F 26% F
Total Return 17.34% 52% F 47% F
Average Annual (5 Year Horizon)  
Capital Gain 4.92% 52% F 58% F
Dividend Return 6.42% 56% F 55% F
Total Return 1.51% 50% F 36% F
Risk Return Profile  
Volatility (Standard Deviation) 21.98% 76% C+ 52% F
Risk Adjusted Return 29.23% 60% D- 52% F
Market Capitalization 3.69B 68% D+ 76% C+

Key Financial Ratios

  Ratio vs. Industry/Classification (Specialty Business Services) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 20.80 44% 28%
Price/Book Ratio 2.88 36% 30%
Price / Cash Flow Ratio 15.74 35% 23%
Price/Free Cash Flow Ratio 13.40 36% 30%
Management Effectiveness  
Return on Equity 11.27% 64% 63%
Return on Invested Capital 8.46% 57% 59%
Return on Assets 4.97% 68% 72%
Debt to Equity Ratio 69.74% 63% 48%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.